Reuters reports the FDA has taken a formal step toward new rules for peptide compounding, a key development for pharmacies and the gray market alike.
Recap by typeshit. Full story at Reuters.
A lawyer named Jeff walks through how his side argues Ozempic, Wegovy and other semaglutide drugs may be linked to NAION, a serious form of sudden vision loss.
Stavros Nicolaou of the Pharmaceutical Task Group wants police to act. SAHPRA says it has seized products and opened criminal cases.
The physician group is pushing back on an FDA plan that would open interim access to unapproved peptides, and wants the White House to block it.
Investigators turned up a warehouse of empty pens and a farm building used as a drug factory, as counterfeit weight loss injection sellers grow more organized.
Philstar Life pushes back on how Ozempic gets talked about, framing it as something other than a weight loss drug. Only the headline is available, so tap through for the argument.
Asked whether injectable peptides or supplements are better, the poster says the first step either way is knowing the maker and what the product really contains.
Loading…